BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26596733)

  • 21. Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.
    Kim MS; Lee HW; Jun SY; Lee EH
    Int J Clin Exp Pathol; 2015; 8(8):8842-56. PubMed ID: 26464626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of high NQO1 expression in breast cancers.
    Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
    J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 (COX2) and p53 protein expression are interdependent in breast cancer but not associated with clinico-pathological surrogate subtypes, tumor aggressiveness and patient survival.
    Serra KP; Peres RM; Sarian LO; Vassallo J; Pinto GA; Silva GR; Soares FA; da Cunha IW; Espinola J; Bento AM; Del Corso LM; Derchain S
    Acta Histochem; 2016 Mar; 118(2):176-82. PubMed ID: 26791786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
    Noda M; Okayama H; Kofunato Y; Chida S; Saito K; Tada T; Ashizawa M; Nakajima T; Aoto K; Kikuchi T; Sakamoto W; Endo H; Fujita S; Saito M; Momma T; Ohki S; Kono K
    PLoS One; 2018; 13(7):e0200315. PubMed ID: 29975776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
    O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
    BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic significance of VEGFR-2 in breast cancer.
    Yan JD; Liu Y; Zhang ZY; Liu GY; Xu JH; Liu LY; Hu YM
    Pathol Res Pract; 2015 Jul; 211(7):539-43. PubMed ID: 25976977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of STIM1 is associated with tumor aggressiveness and poor prognosis in breast cancer.
    Yang Y; Jiang Z; Wang B; Chang L; Liu J; Zhang L; Gu L
    Pathol Res Pract; 2017 Sep; 213(9):1043-1047. PubMed ID: 28869106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of IRS-1 associates with phosphorylated Akt expression and predicts poor prognosis of breast invasive ductal carcinoma.
    Luo J; Feng J; Wen Q; Qoyawayma C; Wang W; Chen L; Lu J; Zhan Y; Xu L; Zang H; Fan S; Chu S
    Hum Pathol; 2018 Sep; 79():9-17. PubMed ID: 29551677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.
    Honma R; Kinoshita I; Miyoshi E; Tomaru U; Matsuno Y; Shimizu Y; Takeuchi S; Kobayashi Y; Kaga K; Taniguchi N; Dosaka-Akita H
    Oncology; 2015; 88(5):298-308. PubMed ID: 25572677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
    Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
    J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.
    Tsuchiya B; Iwaya K; Kohno N; Kawate T; Akahoshi T; Matsubara O; Mukai K
    Histopathology; 2012 Jul; 61(1):69-77. PubMed ID: 22385318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-up.
    Donizy P; Pietrzyk G; Halon A; Kozyra C; Gansukh T; Lage H; Surowiak P; Matkowski R
    Oncol Rep; 2014 Apr; 31(4):1777-87. PubMed ID: 24535158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.